Project Grant 2051416
Award Date
4/1/21
Completion Date
3/31/22
Dollars Obligated
$256K
Federal Agency
Division of Industrial Innovation
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
Kepley Biosystems Inc. received a $255,834 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041). The award period runs from May 1, 2021 through December 31, 2021 to support the development of a rapid, sensitive pathogen typing and antibiotic sensitivity test for bloodstream infections, including COVID-19. The Engineering program seeks to improve quality of life and economic strength through...
Biomesense Inc. received a $255,658 National Science Foundation SBIR Phase I Project Grant to develop a novel biosensor to accelerate investigations of COVID-19 and the gut microbiome. Funded under the NSF Engineering program (CFDA 47.041), this six-month award beginning January 15, 2021 supports the company's work to design a portable, low-cost biosensor device capable of rapidly detecting SARS-CoV-2 and analyzing gut microbiome composition directly from patient samples. The NSF Directorate for...
The National Science Foundation awarded Cytorecovery Inc. a $255,986 Small Business Technology Transfer Phase I Project Grant under the Engineering program (CFDA 47.041) on March 15, 2021. The grant funded the development of on-chip integration of sample preparation and monitoring capabilities with dielectrophoretic cell isolation techniques. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award...
This $984,381 Cooperative Agreement award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of a rapid, direct-from-specimen diagnostic test for identifying and determining antimicrobial susceptibility of major bloodborne bacterial pathogens, including the "ESKAPE" pathogens. The project aims to expand on a technology first developed during a prior SBIR Phase I award, which utilizes bacteriophage...
Frugi Biotechnology Inc. received a $256,000 Project Grant award from the National Science Foundation on August 1, 2021 to develop modular, paper-based, secured diagnostics for managing viral outbreaks such as COVID-19. The award is part of the NSF's Engineering program (CFDA 47.041), which seeks to improve quality of life and economic strength through engineering research and innovation. Under this award, Frugi Biotechnology will leverage its expertise in paper-based diagnostics to create...
The National Science Foundation awarded Ancilia, Inc. a $255,717 Small Business Technology Transfer Phase I Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). The grant will support development of phage-resistant bacterial therapeutics from July 2021 through June 2023. The NSF Technology, Innovation, and Partnerships program seeks to advance science, engineering, and technology innovation to address national challenges. Under this award, Ancilia...
Biochip Labs Inc. received a $256,000 National Science Foundation Project Grant under the Engineering program (CFDA 47.041) for the period of June 1, 2021 through May 31, 2022. The grant funding supports the company's work to develop standardized and reproducible culture and activation methods for endothelial cells in microfluidic devices for drug screening applications. The NSF Engineering program seeks to improve quality of life and economic strength through engineering research and...
Nanopath Inc. received a $255,874 Project Grant award from the National Science Foundation Division of Industrial Innovation on January 1, 2022 for its "Integrated Point-of-Care System for Rapid Pathogen Identification in Urinary Tract Infections" project. The award is part of the NSF's Engineering program (CFDA 47.041), which seeks to improve quality of life and economic strength through engineering research and education. Under the award, Nanopath will develop an integrated...
This $242,687 federal Project Grant award from the National Science Foundation (NSF) Engineering program (CFDA 47.041) aims to develop a next-generation nanopore biosensor technology for the ultrasensitive detection and quantification of multiple infectious disease biomarkers at the point-of-care. The key objectives are to: (1) optimize a highly sensitive, robust, and reproducible nanopore biosensor; (2) enable specific biomarker detection through automated immunoprecipitation and novel signal...
This $402,222 National Science Foundation Project Grant, funded through the Engineering program (CFDA 47.041), supports the development of a new class of simple, inexpensive, portable, and rapid molecular diagnostic platforms. The awardee, University of Cincinnati, will engineer an instrument that can reliably and quickly detect infectious diseases in human samples using a combination of biochemistry, magnetism, fluid physics, and machine learning insights. Specifically, the university will...